Underreporting of Respiratory Viral Infections in Winter Mortality
Overview
A Spanish population-based study found that over one-third of individuals who died during winter tested positive for respiratory viruses postmortem, yet most infections were not diagnosed before death. This discrepancy highlights significant underrecognition of respiratory viral infections in mortality data and clinical practice.
Background
Respiratory viral infections are common during winter months and can contribute to mortality, especially in vulnerable populations. Accurate diagnosis before death is crucial for appropriate clinical management and public health surveillance. However, current testing and reporting systems may fail to capture the true burden of these infections. Molecular diagnostic tools like multiplex PCR offer enhanced detection capabilities but are underutilized in many settings.
Data Highlights
| Parameter | Value |
|---|---|
| Number of individuals studied | 857 |
| Study period | 2016–2020 (four influenza seasons) |
| Percentage positive for ≥1 respiratory virus postmortem | 36% |
| Most common viruses detected postmortem | Rhinovirus (11%), Influenza (11%), Human coronavirus, RSV |
| Influenza listed as cause of death | 1.4% |
| Influenza diagnosed before death among those positive postmortem | 17% |
| Individuals tested for respiratory viruses before death | 11% |
Key Findings
- 36% of deceased individuals tested positive for at least one respiratory virus via postmortem PCR.
- Rhinovirus and influenza were the most frequently detected viruses, each found in 11% of cases.
- Only 1.4% of deaths had influenza recorded as the cause, indicating underreporting.
- Just 17% of those with influenza detected postmortem had been diagnosed with influenza prior to death.
- Only 11% of individuals underwent respiratory virus testing in the 30 days before death.
- Co-infections with multiple respiratory viruses were identified, especially in older or vulnerable patients.
Clinical Implications
Clinicians should maintain a high index of suspicion for respiratory viral infections in vulnerable patients during winter months and consider broader use of molecular diagnostic testing. Improved and more consistent testing, including in community and long-term care settings, may enhance detection and management. Surveillance systems should integrate molecular diagnostics to better capture the true impact of respiratory viruses on mortality.
Conclusion
This study reveals a substantial underrecognition of respiratory viral infections in mortality data, underscoring the need for enhanced diagnostic strategies and surveillance to better understand and address the role of these infections in winter deaths.
Related Resources & Content
- Spanish Population-Based Study 2016–2020 -- Are Respiratory Deaths Underreported?
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
